Measles, pertussis, rubella and mumps completeness of reporting. Literature review of estimates for industrialized countries;Proportion des déclarations de cas de rougeole, de coqueluche, de rubéole et d'oreillons aux systèmes de surveillance. Evaluation des études pour les pays industrialisés

Revue d'Epidemiologie et de Sante Publique

Volumn 54, Issue 1, 2006, Pages 27-39

  Trottier, H ^a,b   Carabin, H ^c   Philippe, P ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Completeness of reporting; Diseases notification; Literature review; Measles; Mumps; Pertussis; Rubella; Surveillance

Indexed keywords

HEALTH SURVEY; HUMAN; INDUSTRIALIZATION; INFECTION CONTROL; INFORMATION PROCESSING; MEASLES; MEDICAL CARE; MEDICAL LITERATURE; MEDLINE; MONITORING; MUMPS; PERTUSSIS; QUANTITATIVE ANALYSIS; REVIEW; RUBELLA;

EID: 33645567338     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0398-7620(06)76692-5     Document Type: Article

References (36)

1. CDC. Update. Global measles control and mortality reduction, worldwide, 1991-2001. MMWR Morb Mortal Wkly Rep 2003; 52: 471-5.
2. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14: 306-15.
3. Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, et al. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis 2003; 187 (suppl 1): S191-7.
4. Stein CE, Birmingham M, Kurian M, Duclos P. Strebel P. The global burden of measles in the year 2000. A model that uses country-specific indicators. J Infect Dis 2003; 187 (suppl 1): S8-14.
5. Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003; 3: 413-8.
6. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ 1999; 77: 3-14.
7. Carabin H, Edmunds WJ, Kou U, Van den Hof S, Nguyen VH. The average cost of measles cases and adverse events following vaccination in industrialised countries. BMC Public Health 2002; 2: 22.
8. Thacker SB, Berkelman RL, Stroup DF. The science of public health surveillance. J Public Health Policy 1989; 10: 187-203.
9. Declich S, Carter AO. Public health surveillance: historical origins, methods and evaluation. Bull World Health Organ 1994; 72: 285-304.
10. Halperin WE. The role of surveillance in the hierarchy of prevention. Am J Ind Med 1996; 29: 321-3.
11. Sydenstricker E. The reporting of notifiable diseases in a typical small city. Hagerstown Morbidity Studies, no II. Public Health Rep 1926; 41: 2186-91.
12. Clarkson JA, Fine PE. The efficiency of measles and pertussis notification in England and Wales. Int J Epidemiol 1985; 14: 153-68.
13. Cherry JD, Feigin RD, Lobes LA Jr, Hinthorn DR, Shackelford PG, Shirley RH, et al. Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr 1972; 81: 217-30.
14. McGrath J, Driver B, Bridges-Webb C, Baker J, Hunter C. The incidence and notification of measles in Australia. Community Health Stud 1989; 13: 156-60.
15. Ewert DP, Frederick PD, Run GH, Mascola L. The reporting efficiency of measles by hospitals in Los Angeles County, 1986 and 1989. Am J Public Health 1994; 84: 868-9.
16. Ewert DP, Westman S, Frederick PD, Waterman SH. Measles reporting completeness during a community-wide epidemic in inner-city Los Angeles. Public Health Rep 1995; 110: 161-5.
17. Davis SF, Strebel PM, Atkinson WL, Markowitz LE, Sutter RW, Scanlon KS, et al. Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health 1993; 83: 1011-5.
18. Nordin JD, Harpaz R, Harper P, Rush W. Syndromic surveillance for measles-like illnesses in a managed care setting. J Infect Dis 2004; 189 (suppl 1): S222-6.
19. Kolasa M, Alexopoulos N, Diaz P, Kellachan J, Lowrey MJ, Shelton B, et al. Measles surveillance in five major US cities: Chicago, Houston, Los Angeles, Miami, and New York. J Infect Dis 2004; 189 (suppl 1): S216-21.
20. McDonnell LF, Jorm LR. Measles epidemic in western Sydney. New South Wales Public Health Bulletin 1994; 5: 59-60.
21. Allen CJ, Ferson MJ. Notification of infectious diseases by general practitioners: a quantitative and qualitative study. Med J Aust 2000; 172: 325-8.
22. Jenkinson D. Whooping cough: what proportion of cases is notified in an epidemic? Br Med J (Clin Res Ed) 1983; 287: 185-6.
23. Sutter RW, Cochi SL. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. J Am Med Assoc 1992; 267: 386-91.
24. Deeks S, De Serres G, Boulianne N, Duval B, Rochette L, Dery P, et al. Failure of physicians to consider the diagnosis of pertussis in children. Clin Infect Dis 1999; 28: 840-6.
25. Harpaz R. Completeness of measles case reporting: review of estimates for the United States. J Infect Dis 2004; 189 (suppl 1): S185-90.
26. Doyle TJ, Glynn MK, Groseclose SL. Completeness of notifiable infectious disease reporting in the United States: an analytical literature review. Am J Epidemiol 2002; 155: 866-74.
27. Halperin SA, Bortolussi R, MacLean D, Chisholm N. Persistence of pertussis in an immunized population: results of the Nova Scotia Enhanced Pertussis Surveillance Program. J Pediatr 1989; 115: 686-93.
28. Rivest P, Richer F, Bedard L. Difficultés associées à la surveillance de la coqueluche. Can Commun Dis Rep 2004; 30: 29-33, 36.
29. Santé Canada. Rapport d'une réunion du comité consultatif d'experts sur la rubéole au Canada. Can Commun Dis Rep 2002; 28: S4.
30. King A, Varughese P, De Serres G, Tipples GA, Waters J; Working Group on Measles Elimination. Measles elimination in Canada. J Infect Dis 2004; 189 (suppl 1): S236-42.
31. De Serres G, Boulianne N, Bussières N, Pouliot B, Marin-Lira A. Épidémiologie des oreillons au Québec, 1970-1995. Can Commun Dis Rep 1997; 23: 9-13.
32. Gaulin C, De Serres G. Nécessité d'utiliser une définition spécifique d'oreillons dans une population hautement vaccinée. Can Commun Dis Rep 1997; 23: 14-6.
33. Brunell PA, Brickman A, Steinberg S, Allen E. Parotidis in children who had previously received mumps vaccine. Pediatrics 1972; 50: 441-4.
34. Santé et Bien-Être social Canada. Résultats de laboratoire concernant les infections virales au Canada. Can Dis Wkly Rep 1983; 9: 133-6.
35. Brewster D. Surveillance of measles in Scotland 1983-1991. A comparison of statutory notification and laboratory reporting. J Infect 1993; 27: 193-201.
36. Torvaldsen S, McIntyre P. Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSW. New South Wales Public Health Bulletin 2003; 14: 81-4.